Tag: PVI
Volta Medical’s AI-guided cardiac ablation procedure found to improve AF treatments
Volta Medical has announced the publication in Nature Medicine of the TAILORED-AF clinical trial, which demonstrated that an artificial intelligence (AI)-guided procedure for persistent atrial...
Cardiac Rhythm News’ top stories of 2024
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
ESC 2024: Widely performed additional ablation procedure deemed ineffective in persistent...
In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in...
ESC 2024: Mainstay ablation procedure for atrial fibrillation shows “substantial benefit”...
A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF), and results...
EHRA 2023: Novel ablation strategy increases freedom from arrhythmia in AF...
An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation (AF)...
AF Symposium hears late-breaking data from RFA and PFA trials
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
Study reveals low reconnection rate with large antral lesion at PW...
A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...
Study shares success of complete PVI using only pulsed field ablation
A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...